Boston Scientific will buy Penumbra for $14.5 billion, or $374 a share, expanding its cardiovascular reach. Penumbra stock ...

Penumbra agreed to be acquired by rival Boston Scientific for $374 a share, the companies announced Thursday.

Boston Scientific has agreed to acquire Penumbra in a deal worth around $14.5bn, a move that will expand the medtech giant’s ...

It’s beginning to feel a lot like the days of the perfunctory take on holiday arts programming are behind us. Something in the air at Twin Cities performances this year suggests a renewed commitment ...

ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Penumbra Inc. (PEN) on Wednesday reported third-quarter profit of $45.9 million. On a per-share basis, the Alameda, California-based company said it had ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

TCT 1706: Stentless Percutaneous Coronary Intervention in Acute Coronary Syndrome With Large Thrombus Burden: A Case Series Using Intravascular Imaging, Penumbra Aspiration, Plain Old Balloon ...

Aspiration co-founder Joe Sanberg, now at the heart of an NBA investigation into potential cap circumvention involving the LA Clippers, pleaded guilty in federal court Monday. Icon Sportswire / Getty ...

Penumbra, Inc. (NYSE:PEN) ranks among the best medical device stocks to invest in. Needham raised Penumbra, Inc. (NYSE:PEN) from Hold to Buy on October 8 and set a $326 price target on the company’s ...